First came a reduction in funding to Africa by the United States Agency for International Development (USAID).
This was followed by a confirmed report that the United States has withdrawn its membership from the World Health Organisation (WHO).
Taken together, these decisions represent a significant shift in U.S. engagement with multilateral health and development institutions.
For Africa—where external financing remains deeply embedded in public health systems, disease surveillance, and emergency response—the implications are profound. They are not immediate or dramatic, but they are structural, cumulative, and potentially destabilising.
For many people, the consequences may appear abstract or even invisible. Most will wake up to this news feeling unchanged, and in the short term, that perception will be accurate. There will be no sudden collapse of hospitals, no instant spike in mortality, and no single moment that can be clearly identified as the point of failure.
The real impact of decisions of this nature lies not in the present, but in the future—in the slow erosion of systems whose value is only fully appreciated when they fail.
One concrete example illustrates this point clearly. The World Health Organisation coordinates the world’s largest global surveillance system for antimicrobial resistance. This system tracks the emergence and spread of drug-resistant infections across countries and continents, providing critical data that informs treatment protocols, research priorities, and public health responses worldwide.
Antimicrobial resistance occurs when infections no longer respond to standard antibiotics, leading to longer illnesses, higher medical costs, and increased risk of death. The reason many patients recover today after being prescribed antibiotics is precisely that such surveillance systems help detect resistance patterns early and guide effective responses.
When the United States withdraws from the WHO, the organisation loses a major source of financial support, about 20% of such support, and technical support for this surveillance infrastructure. Over time, this translates into weaker data collection, reduced monitoring capacity, and a diminished understanding of where resistant pathogens are emerging and how they are spreading. The result is not an immediate crisis, but a gradual increase in undetected transmission.
Years from now—perhaps a decade or two—a patient may be hospitalised with an infection that no longer responds to available antibiotics. By then, it will be impossible to trace that outcome to a single political decision.
Yet part of the explanation may lie in today’s withdrawal from global health coordination mechanisms. By the time the consequences become fully visible, reversing them may no longer be possible.
This is the nature of policy decisions in global health: they rarely hurt immediately, but when they do, they hurt deeply—and often too late.
Implications for Africa
For Africa, the immediate risk lies in reduced funding for programmes that address malaria, tuberculosis, HIV/AIDS, maternal and child health, and epidemic preparedness. Many of these interventions are either directly or indirectly supported through WHO-coordinated mechanisms, often complemented by USAID and other bilateral donors.
A weakened WHO could also compromise disease surveillance systems that African countries rely on for early detection and response. In an interconnected world, delayed reporting or inadequate coordination can turn local outbreaks into regional or global crises.
Beyond health outcomes, there is a broader governance concern. Africa’s heavy reliance on external funding exposes the continent to policy shifts in donor capitals—decisions over which African governments have little influence but must bear the consequences.
What This Means for Ghana
Ghana’s health sector, while relatively more structured than many in the region, is not insulated from these shocks. Key public health programmes—particularly in immunisation, disease control, health research, and emergency preparedness—have long benefited from donor support and multilateral coordination.
A reduction in WHO-linked funding and technical assistance could increase fiscal pressure on government, forcing difficult trade-offs within an already constrained budget environment. This comes at a time when Ghana is pursuing economic stabilisation and debt restructuring, limiting its immediate fiscal flexibility.
There is also a strategic risk. Public health emergencies do not respect borders. Any weakening of global coordination mechanisms increases Ghana’s vulnerability to pandemics, cross-border disease transmission, and supply chain disruptions for essential medicines and vaccines.
Beyond the Immediate Shock: A Wake-Up Call
While the U.S. withdrawal presents clear risks, it also exposes a longstanding structural weakness: Africa’s overdependence on external actors for core development and health functions.
The uncomfortable truth is that sustainable health systems cannot be built on unpredictable donor goodwill. External support should complement—not substitute—domestic investment, institutional capacity, and political commitment.
For Ghana, this moment should prompt a serious reassessment of health financing. Expanding domestic resource mobilisation, improving efficiency in health spending, and strengthening accountability within the sector are no longer optional—they are strategic imperatives.
The Role of Regional and Continental Institutions
At the continental level, institutions such as the Africa Centres for Disease Control and Prevention (Africa CDC) must be strengthened, both politically and financially. Regional cooperation through ECOWAS can also help pool resources, share data, and coordinate responses to health threats.
This is not an argument for isolation or disengagement from global systems. Rather, it is a call for balanced partnerships—where Africa participates as a capable actor, not a perpetual dependent.
What Ghana Must Do Now
First, Ghana must prioritise health as a core national security issue, not merely a social sector concern. Pandemics, food insecurity, and climate-related health risks have direct economic and political consequences.
Second, the government must explore innovative financing mechanisms, including health insurance reform, public-private partnerships, and targeted levies for health security and research.
Third, Ghana should actively engage other global partners and emerging economies to diversify cooperation and reduce exposure to unilateral policy shifts.
Finally, this moment calls for leadership. Transparent communication with the public, evidence-based policymaking, and long-term planning are essential to maintaining confidence in the health system.
Conclusion
The U.S. withdrawal from the WHO is more than a diplomatic decision; it is a stress test for global health governance and a stark reminder of Africa’s vulnerabilities. For Ghana, the challenge is twofold: mitigating immediate risks while using this moment to build a more resilient, self-reliant health system.
If handled strategically, this crisis can become a turning point—one that moves Ghana, and Africa more broadly, from dependence to durable capacity. The cost of inaction, however, would be far higher than the cost of reform.
